Trials / Completed
CompletedNCT02308124
Treatment and Prognosis of Neurogenic Orthostatic Hypotension : A Prospective Randomized Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 87 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Compare the effect of treatment of midodrine and pyridostigmine in neurogenic orthostatic hypotension and investigate the quality of life of treatment of neurogenic orthostatic hypotension.
Detailed description
In patients with neurogenic orthostatic hypotension, the appropriate treatment was identified by comparing the treatment effects and side effects for each treatment drug. In addition, by confirming the effect of orthostatic hypotension on lowering the quality of life, it is expected that the improvement of the quality of life will help.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Midodrine | |
| DRUG | Pyridostigmine Bromide | |
| DRUG | Midodrine + pyridostigmine |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2016-09-01
- Completion
- 2016-09-01
- First posted
- 2014-12-04
- Last updated
- 2021-10-19
- Results posted
- 2017-04-17
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02308124. Inclusion in this directory is not an endorsement.